MedTrace Logo

A Pilot Study of Effect of Dexmedetomidine on Sleep and Inflammation in Critically Ill Patients

NCT00405847 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2016-10-27

No results posted yet for this study

Summary

The purpose of this study is to assess the short-term effect of sympatholysis on sleep quality and inflammation in critically ill patients.

Conditions

  • Sleep
  • Critical Illness

Interventions

DRUG

Dexmedetomidine

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Principal Investigators

  • Sairam Parthasarathy, MD · SAVAHCS and University of Arizona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00405847 on ClinicalTrials.gov